Aditxt secured new financing and consolidated outstanding debt obligations through a senior secured convertible note transaction.

Aditxt (NASDAQ: ADTX) announced a senior secured note purchase agreement involving its wholly owned subsidiary Ignite Proteomics LLC.

Under the transaction, the company will issue a new series of senior secured convertible notes to accredited institutional investors. The financing provides approximately $725,000 in immediate proceeds while also consolidating debt obligations previously issued during March and April 2026.

Management stated that combining multiple debt instruments into a single structure may simplify the company's capital framework. Investors are evaluating the potential liquidity benefits alongside the implications of future note conversions.

The transaction highlights ongoing efforts by smaller biotechnology and healthcare companies to secure capital while managing existing liabilities in a challenging financing environment.